Search Results - "Aranda ‐Michel, Jaime"

Refine Results
  1. 1

    Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors by Taner, C. Burcin, Bulatao, Ilynn G., Willingham, Darrin L., Perry, Dana K., Sibulesky, Lena, Pungpapong, Surakit, ArandaMichel, Jaime, Keaveny, Andrew P., Kramer, David J., Nguyen, Justin H.

    Published in Liver transplantation (01-01-2012)
    “…The use of donation after cardiac death (DCD) liver grafts is controversial because of the overall increased rates of graft loss and morbidity, which are…”
    Get full text
    Journal Article
  2. 2

    Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus by Taner, C. Burcin, Bulatao, Ilynn G., Keaveny, Andrew P., Willingham, Darrin L., Pungpapong, Surakit, Perry, Dana K., Rosser, Barry G., Harnois, Denise M., ArandaMichel, Jaime, Nguyen, Justin H.

    Published in Liver transplantation (01-06-2011)
    “…Hepatitis C virus (HCV) infection is the most common indication for orthotopic liver transplantation in the United States. Although studies have addressed the…”
    Get full text
    Journal Article
  3. 3

    Liver transplantation and pancreatic resection: A single‐center experience and a review of the literature by Stauffer, John A., Steers, Jeffery L., Bonatti, Hugo, Dougherty, Marjorie K., ArandaMichel, Jaime, Dickson, Rolland C., Harnois, Denise M., Nguyen, Justin H.

    Published in Liver transplantation (01-12-2009)
    “…Liver transplantation may occasionally be indicated in patients with unique clinical scenarios. Little is known regarding the outcomes of patients who have had…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Liver Disease and Osteoporosis by Sanchez, Antonio J., Aranda-Michel, Jaime

    Published in Nutrition in Clinical Practice (01-06-2006)
    “…Metabolic bone disease (osteodystrophy) is an important complication of patients with chronic liver disease; its etiology is complex and multifactorial…”
    Get full text
    Book Review Journal Article
  6. 6

    Preexisting atrial fibrillation and cardiac complications after liver transplantation by Bargehr, Johannes, Trejo‐Gutierrez, Jorge F., Patel, Tushar, Rosser, Barry, ArandaMichel, Jaime, Yataco, Maria L., Taner, C. Burcin

    Published in Liver transplantation (01-03-2015)
    “…Atrial fibrillation (AF) is the most common cardiac arrhythmia, and it is associated with increased cardiovascular morbidity and all‐cause mortality. Our aim…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Nutrition for the liver transplant patient by Sanchez, Antonio J., ArandaMichel, Jaime

    Published in Liver transplantation (01-09-2006)
    “…Patients with end‐stage liver disease (ESLD) frequently have diverse abnormalities of carbohydrate, lipid, and protein metabolism that cause progressive…”
    Get full text
    Journal Article
  9. 9

    Nutritional support in head injury by Vizzini, Angela, R.D, Aranda-Michel, Jaime, M.D

    “…Abstract Nutritional support is imperative to the recovery of head-injury patients. Hypermetabolism and hypercatabolism place this patient population at…”
    Get full text
    Journal Article
  10. 10

    Reversible non-ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single-centre experience by Yataco, Maria L., Difato, Thomas, Bargehr, Johannes, Rosser, Barry G., Patel, Tushar, Trejo-Gutierrez, Jorge F., Pungpapong, Surakit, Taner, C. Burcin, Aranda-Michel, Jaime

    Published in Liver international (01-07-2014)
    “…Background & Aims Non‐ischaemic cardiomyopathy (NIC) is an early complication of liver transplantation (LT). Our aims were to define the prevalence, associated…”
    Get full text
    Journal Article
  11. 11

    Gastroparesis: From Concepts to Management by Bouras, Ernest P., Vazquez Roque, Maria I., Aranda-Michel, Jaime

    Published in Nutrition in clinical practice (01-08-2013)
    “…While the symptoms of gastroparesis are common, an accurate diagnosis is based on a combination of those symptoms with a documented delay in gastric emptying…”
    Get full text
    Journal Article
  12. 12

    Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence by Ghabril, Marwan, Dickson, Rolland C., Krishna, Murli, Machicao, Victor, ArandaMichel, Jaime, Bonatti, Hugo, Nguyen, Justin H.

    Published in Liver transplantation (01-06-2011)
    “…Factors present prior to liver transplantation (LT) that predict fibrosis progression in recurrent hepatitis C infection (HCV) after LT would be important to…”
    Get full text
    Journal Article
  13. 13

    Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients by Martin, Jill E., Cavanaugh, Teresa M., Trumbull, Leslie, Bass, Maryetta, Weber Jr, Fredrick, Aranda-Michel, Jaime, Hanaway, Michael, Rudich, Steven

    Published in Clinical transplantation (01-01-2008)
    “…:  Transplant patients are at increased risk of developing dyslipidemia, which contributes to coronary artery disease and cardiovascular events. The purpose of…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study by Gearhart, Michelle, Martin, Jill, Rudich, Steve, Thomas, Mark, Wetzel, Dave, Solomkin, Joseph, Hanaway, Michael J, Aranda-Michel, Jaime, Weber, Fred, Trumball, Leslie, Bass, Maryetta, Zavala, Ed, Steve Woodle, E, Buell, Joseph F

    Published in Clinical transplantation (01-12-2005)
    “…:  Background:  Liver transplant recipients are at high risk for multi‐drug resistant infections because of broad‐spectrum antibiotic and immunosuppression…”
    Get full text
    Journal Article
  17. 17

    Recurrent liver failure caused by IgG4 associated cholangitis by Clendenon, Jacob N, Aranda-Michel, Jaime, Krishna, Murli, Taner, C Burcin, Willingham, Darrin L

    Published in Annals of hepatology (01-10-2011)
    “…Immunoglobulin G4 associated cholangitis (IAC) is an autoimmune disease associated with autoimmune pancreatitis (AIP). It presents with clinical and…”
    Get full text
    Journal Article
  18. 18

    Improving graft survival for patients undergoing liver transplantation by Dickson, Rolland C., Pungpapong, Surakit, Keaveny, Andrew P., Taner, C. Burcin, Ghabril, Marwan, Aranda-Michel, Jaime, Satyanarayana, Raj, Bonatti, Hugo, Kramer, David J., Nguyen, Justin H.

    Published in Clinical transplantation (01-05-2011)
    “…Dickson RC, Pungpapong S, Keaveny AP, Taner BC, Ghabril M, Aranda‐Michel J, Satyanarayana R, Bonatti H, Kramer DJ, Nguyen JH. Improving graft survival for…”
    Get full text
    Journal Article
  19. 19

    Dual hepatitis virus infections in liver transplant: case report and a review of the literature by Yataco, Maria L., Dickson, Rolland C., Bonatti, Hugo, ArandaMichel, Jaime, Mendez, Julio, Ghabril, Marwan, Nguyen, Justin

    Published in Clinical transplantation (01-03-2009)
    “…:  Background:  Liver transplantation (LT) using grafts from anti‐HBVcore antibody‐positive (anti‐HBVcAB+) donors carry risk for development of hepatitis B…”
    Get full text
    Journal Article
  20. 20

    Patient Selection for Liver Transplant: 1-Year Experience With 555 Patients at a Single Center by Aranda-Michel, Jaime, MD, Dickson, Rolland C., MD, Bonatti, Hugo, MD, Crossfield, John R., MA, Keaveny, Andrew P., MD, Vasquez, Adriana R., MD

    Published in Mayo Clinic proceedings (01-02-2008)
    “…Liver transplant (LT) has revolutionized the management of end-stage liver disease in the past 2 decades. The institution of the Model for End-Stage Liver…”
    Get full text
    Journal Article